JAMES SAPIRSTEIN

CIK 1559509 · Chief Executive Officer · last filed 2026-06-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.5K

Companies

9

Total Filings

47

Lifetime Open-Market Net

-$11.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
COCP Chief Executive Officer $0.99 $0 1 2026-06-03
ZVSA Director $0.20 $0 2 2025-07-15
ONCO Director 3,477 $1.02 $3.5K $0 1 2024-09-30
GridAI Technologies Corp. (FWBI) Delisted Chairman and CEO 35,816 $2.96 $106.0K -$26.5K 10 2024-07-03
RENOVARO INC. (RENB) Delisted Director $1.54 $0 2 2024-06-27
Onconetix, Inc. (BWV) Delisted Director 6,360 $0.18 $1.1K $0 2 2023-06-01
RENOVARO INC. (ENOB) Delisted Director $0.70 $0 3 2023-04-04
GridAI Technologies Corp. (AZRX) Delisted PRES, CEO & CHAIRMAN OF BOARD 200,000 $3.45 $690.0K $0 3 2021-07-02
Hepion Pharmaceuticals, Inc. (CTRV) Delisted Chief Executive Officer 492,819 $15.2K 9 2018-01-05

Recent Filings · Page 4 of 5

47 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-03-07 Hepion Pharmaceuticals, Inc. (CTRV) Delisted Grant (A) $0 EDGAR
2017-02-15 Grant (A) +75,000 $59.2K
2017-01-20 Grant (A) $0
2016-10-31 Hepion Pharmaceuticals, Inc. (CTRV) Delisted Exer (M) +16,666 $25.0K EDGAR
2016-06-14 Hepion Pharmaceuticals, Inc. (CTRV) Delisted Grant (A) $0 EDGAR
2016-04-04 Grant (A) $0
2016-02-18 Hepion Pharmaceuticals, Inc. (CTRV) Delisted Buy (P) +10,000 $10.0K EDGAR
2015-12-01 Hepion Pharmaceuticals, Inc. (CTRV) Delisted Buy (P) +500 $1.1K EDGAR
2015-11-24 Hepion Pharmaceuticals, Inc. (CTRV) Delisted Buy (P) +2,500 $4.1K EDGAR
2015-08-20 Grant (A) $0
Showing 3140 of 47
Page 4 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.